Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,078.74
(
-0.43%
)
US TECH 100
25,821.80
(
-0.19%
)
Dow Jones
49,223.47
(
-0.45%
)
Brent Oil
93.65
(
3.28%
)
Bitcoin
75,606.40
(
-0.38%
)
News Focus
News Focus
Post# of 57795
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

gfp927z

Send PM Follow Ignore
Followers 97
Posts 38776
Boards Moderated 89
Alias Born 03/22/2005

gfp927z

Re: neuroinv post# 37827

Wednesday, 10/26/2011 1:50:19 PM

Wednesday, October 26, 2011 1:50:19 PM

Post# of 57795
Neuro, Thanks. But will a US/Euro pharma partner want to share ownership of a particular compound with another entity who is also running trials on the same compound?

Isn't split ownership of a compound what partners avoid? Otherwise, if Samyang has a safety/side effect problem with CX-1739, real or perceived, the other partner of CX-1739 has a big problem also.













































































































Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now